期刊文献+

肥胖/糖尿病与肿瘤的相关性及其分子机制的研究进展 被引量:12

The Correlation and Molecular Mechanisms between Obesity/Diabetes and Cancer
原文传递
导出
摘要 全球范围内,肥胖、糖尿病和肿瘤的发病率持续上升,已成为严重危害人类生命健康、降低人类生活质量的全球性重大公共卫生问题。近来研究发现,肥胖/糖尿病与肿瘤的关系密切,然而其分子机制尚不十分明确。目前已发现的可能的分子机制有胰岛素抵抗作用、糖代谢异常、慢性炎症反应、免疫系统失调、肥胖相关基因过度表达、癌基因与抑癌基因的异常表达、白色脂肪组织的功能紊乱等。阐明肥胖/糖尿病与肿瘤的关系及相关的分子机制,对个人和全社会都具有非常重要的意义,因此本文围绕肥胖/糖尿病与肿瘤的关系及其分子机制进行全面系统的综述。 Worldwide, obesity, diabetes and cancer incidence is increasing continually, and have become the global serious public health issues that greatly harm people's health and lower the life quality. Recent studies have found that obesity / diabetes is closely related to tumor, but its molecular mechanism is not very clear. It has been found that the possible molecular mechanisms, such as the action of insulin resistance, abnormal glucose metabolism, chronic inflammatory reaction, immune system disorders, overexpressed obesity related genes(such as FTO and NYGGF4), oncogene and anti abnormal expression of cancer genes(such as N-myc, p53), white fat tissue endocrine function. To clarify the relationship and the molecular mechanisms between obesity/diabetes and tumor, it is important for individuals and the whole society.
出处 《现代生物医学进展》 CAS 2017年第1期177-180,193,共5页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(81201928)
关键词 肥胖 糖尿病 肿瘤 分子机制 Obesity Diabetes Tumor Molecular mechanisms
  • 相关文献

参考文献1

二级参考文献29

  • 1Shore SA, Fredberg JJ. Obesity, smooth muscle, and airway hyperresp- onsiveness[J]. J Allergy C|in Immunol, 2005, 115:925-927.
  • 2Pfeiler G, Treeck O, Wenzel G, et al. Influence of insulin resistance on adiponectin receptor expression in breast cancer [J]. Maturitas, 2009, 63(3):253-256.
  • 3Takemura Y, Osuga Y, Yamauchi T, et al. Expression of adiponectin receptors and its possible implication in the human endomea'ium [J]. Endocrinology, 2006, 147(7):3203-3210.
  • 4Yoneda K, Tomimoto A, Endo H, et al. Expression of adiponeetin rec- eptors, AdipoR1 and AdipoR2, in normal colon epithelium andcolon cancer tissue[J]. Oncol Rep, 2008, 20(3):479-483.
  • 5Petridou E, Mantzoros C, Dessypris N, et al. Plasma adiponectin conc- entrations in relation to cudometriat cancer: a case-control study iaG-r- eece[J]. J Clin Endocrinol Metab, 2003, 88(3):993-997.
  • 6Dal Maso L, Augustin LS, Karalis A, et al. Circulating adiponectin and endometrial cancer risk[J]. J Clin Endoefinol Metab, 2004, 89(3):1160- 1163.
  • 7Soliman PT, Wu D, Tortolero-Luna G, et al. Association between adip- oneetin insulin resistance, and endometrial cancer [J]. Cancer, 2006, 106(11):2376-2381.
  • 8Rzepka-G6rska I, Bedner R, Cymbaluk-Ploska A, et al. Serum adipon- ectin in relation to endometrial cancer and endometrial hyperplasia w- ith atypia in obese women[J]. Eur J GynaecoI Oncol, 2008, 29(6):594- 597.
  • 9lshikawa M, Kitayama J, Kazama S, et al. Plasma adiponectin and gastric cancer[J]. Clin Cancer Res, 2005, 11(2 Pt 1):466-472.
  • 10Wei EK, Giovannucci E, Fuchs CS, et al. Low plasma adiponectin le- vels and risk ofcolorectal cancer in men: a prospective study[J]. J N- atl Cancer Inst, 2005, 97(22): 1688-1694.

共引文献6

同被引文献83

引证文献12

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部